In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA

    loading  Checking for direct PDF access through Ovid

Abstract

Our primary aim was to compare neuroinflammation in cognitively intact control subjects and patients with Alzheimer's disease (AD) by using positron emission tomography (PET) with translocator protein 18kDa (TSPO)-specific radioligand [18F]-FEPPA. [18F]-FEPPA PET scans were acquired on a high-resolution research tomograph in 21 patients with AD (47- 81 years) and 21 control subjects (49-82 years). They were analyzed by using a 2-tissue compartment model with arterial plasma input function. Differences in neuroinflammation, indexed as [18F]-FEPPA binding were compared, adjusting for differences in binding affinity class as determined by a single polymorphism in the TSPO gene (rs6971). In grey matter areas, [18F]-FEPPA was significantly higher in AD compared with healthy control subjects. Large increases were seen in the hippocampus, prefrontal, temporal, parietal and occipital cortex (average Cohen's d = 0.89). Voxel-based analyses confirmed significant clusters of neuroinflammation in the frontal, temporal and parietal cortex in patients with AD. In white matter, [18F]-FEPPA binding was elevated in the posterior limb of the internal capsule, and the cingulum bundle. Higher neuroinflammation in the parietal cortex (r = - 0.7, P = 0.005), and posterior limb of the internal capsule (r = - 0.8, P = 0.001) was associated with poorer visuospatial function. In addition, a higher [18F]-FEPPA binding in the posterior limb of the internal capsule was associated with a greater impairment in language ability (r = - 0.7, P = 0.004). Elevated neuroinflammation can be detected in AD patients throughout the brain grey and white matter by using [18F]-FEPPA PET. Our results also suggest that neuroinflammation is associated with some cognitive deficits.

Related Topics

    loading  Loading Related Articles